Skip to main content
. 2002 Nov;61(Suppl 2):ii64–ii66. doi: 10.1136/ard.61.suppl_2.ii64

Figure 2 .

Figure 2

MN 302/4 two year cohort (baseline to year 2). Mean/median, interquartile ranges by tertiles of estimated yearly progression at baseline. Percentages represent the distribution of patients in each tertile in the year 2 cohort. LEF, leflunomide; MTX, methotrexate.